Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lourenço BC"'
Autor:
Aragão JA; Universidade Federal de Sergipe - UFS, Aracaju, SE, Brasil., Neves OMG; Fundação Beneficência Hospital Cirurgia - FBHC, Serviço de Cirurgia Vascular, Aracaju, SE, Brasil., Aragão ICS; Hospital Municipal Munir Rafful - HMMR, Volta Redonda, RJ, Brasil., Aragão FMS; Faculdade de Medicina de São José do Rio Preto - FAMERP, São José do Rio Preto, SP, Brasil., Lourenço BC; Faculdade de Ciências Médicas de Três Rios - FCM-TR, Três Rios, RJ, Brasil., Porto LC; Centro Universitário Tiradentes - UNIT, Maceió, AL, Brasil., Marassi PHA; Hospital Naval Marcílio Dias - HNMD, Rio de Janeiro, RJ, Brasil., Reis FP; Universidade Tiradentes - UNIT, Aracaju, SE, Brasil.; Centro Universitário Alfredo Nasser - UNIFAN, Aparecida de Goiânia, GO, Brasil.
Publikováno v:
Jornal vascular brasileiro [J Vasc Bras] 2023 Dec 18; Vol. 22, pp. e20230082. Date of Electronic Publication: 2023 Dec 18 (Print Publication: 2023).
Autor:
Lourenço BC; Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal., Amorim-Barbosa T; Department of Orthopaedics, Centro Hospitalar Universitário do Porto, Porto, Portugal., Lemos C; Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal.; UnIGENe, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal., Rodrigues-Pinto R; Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal.; Department of Orthopaedics, Centro Hospitalar Universitário do Porto, Porto, Portugal.; Department of Orthopaedics, Spinal Unit (UVM), Centro Hospitalar Universitário do Porto, Porto, Portugal.
Publikováno v:
Porto biomedical journal [Porto Biomed J] 2023 Apr 10; Vol. 8 (2), pp. e207. Date of Electronic Publication: 2023 Apr 10 (Print Publication: 2023).
Autor:
Lourenço BC; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), 4200-072 Porto, Portugal., Guimarães-Teixeira C; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal., Flores BCT; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal., Miranda-Gonçalves V; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; Department of Pathology and Molecular Immunology, ICBAS-School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal., Guimarães R; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), 4200-072 Porto, Portugal., Cantante M; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), 4200-072 Porto, Portugal., Lopes P; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), 4200-072 Porto, Portugal., Braga I; Department of Urology, Portuguese Oncology Institute of Porto (IPOP), 4200-072 Porto, Portugal., Maurício J; Department of Medical Oncology, Portuguese Oncology Institute of Porto (IPOP), 4200-072 Porto, Portugal., Jerónimo C; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; Department of Pathology and Molecular Immunology, ICBAS-School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal., Henrique R; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), 4200-072 Porto, Portugal.; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; Department of Pathology and Molecular Immunology, ICBAS-School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal., Lobo J; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), 4200-072 Porto, Portugal.; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; Department of Pathology and Molecular Immunology, ICBAS-School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, 4050-513 Porto, Portugal.
Publikováno v:
Life (Basel, Switzerland) [Life (Basel)] 2022 Feb 10; Vol. 12 (2). Date of Electronic Publication: 2022 Feb 10.